These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 22240623
1. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA. Krönke A, Schlaak M, Arin M, Mauch C, Kurschat P. Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623 [No Abstract] [Full Text] [Related]
2. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A. Coors EA, Von den Driesch P. Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024 [No Abstract] [Full Text] [Related]
6. Juvenile mycosis fungoides treated with bexarotene and PUVA. Rodríguez-Vázquez M, García-Arpa M, González-García J. Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731 [Abstract] [Full Text] [Related]
7. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate. Dalle S, Thomas L. Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186 [No Abstract] [Full Text] [Related]
8. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA]. Wirtz M, Helbig D. Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704 [Abstract] [Full Text] [Related]
10. Folliculotropic mycosis fungoides and a leonine clinical appearance of the face. Ito T, Yamamoto T, Matsumoto Y, Wakamatsu J, Kato Y, Tsuboi R. Dermatol Online J; 2008 Sep 15; 14(9):6. PubMed ID: 19061588 [Abstract] [Full Text] [Related]
11. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB. D'Acunto C, Gurioli C, Neri I. J Dermatolog Treat; 2010 Jan 15; 21(1):45-8. PubMed ID: 19603308 [Abstract] [Full Text] [Related]
12. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene. Mehlmauer MA. Cutis; 2004 Jun 15; 73(6):417-20. PubMed ID: 15224787 [Abstract] [Full Text] [Related]
13. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Whittaker S, Ortiz P, Dummer R, Ranki A, Hasan B, Meulemans B, Gellrich S, Knobler R, Stadler R, Karrasch M. Br J Dermatol; 2012 Sep 15; 167(3):678-87. PubMed ID: 22924950 [Abstract] [Full Text] [Related]
14. Follicular mycosis fungoides: variability of a rare entity. Roeschm A, Schleyer V, Landthaler M, Vogt T. Skinmed; 2005 Sep 15; 4(1):12-7. PubMed ID: 15654159 [Abstract] [Full Text] [Related]
15. Bexarotene monotherapy for patients with advanced stage mycosis fungoides. Bachelez H. Dermatol Clin; 2008 Jan 15; 26 Suppl 1():25-6. PubMed ID: 18405183 [No Abstract] [Full Text] [Related]
17. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides. Huang J, Cowper S, Moss J, Girardi M. J Drugs Dermatol; 2013 Apr 15; 12(4):487-9. PubMed ID: 23652902 [Abstract] [Full Text] [Related]